GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qualitek Labs Ltd (BOM:544091) » Definitions » EBIT

Qualitek Labs (BOM:544091) EBIT : ₹65.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Qualitek Labs EBIT?

Qualitek Labs's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹30.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹65.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Qualitek Labs's annualized ROC % for the quarter that ended in Sep. 2024 was 5.84%. Qualitek Labs's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 14.47%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Qualitek Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.03%.

Qualitek Labs EBIT Historical Data

The historical data trend for Qualitek Labs's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qualitek Labs EBIT Chart

Qualitek Labs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EBIT
3.94 7.70 46.32 67.34

Qualitek Labs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24
EBIT Get a 7-Day Free Trial - - 31.76 35.57 30.34

Competitive Comparison of Qualitek Labs's EBIT

For the Diagnostics & Research subindustry, Qualitek Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qualitek Labs's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qualitek Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Qualitek Labs's EV-to-EBIT falls into.


Qualitek Labs EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹65.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qualitek Labs  (BOM:544091) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Qualitek Labs's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=60.49 * ( 1 - 26.95% )/( (464.398 + 1049.573)/ 2 )
=44.187945/756.9855
=5.84 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=505.888 - 23.776 - ( 17.714 - max(0, 68.841 - 117.096+17.714))
=464.398

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1088.94 - 38.7 - ( 0.667 - max(0, 143.042 - 254.429+0.667))
=1049.573

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Qualitek Labs's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=60.676/( ( (371.157 + max(32.472, 0)) + (429.387 + max(5.903, 0)) )/ 2 )
=60.676/( ( 403.629 + 435.29 )/ 2 )
=60.676/419.4595
=14.47 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(78.539 + 0 + 1.964) - (23.776 + 0 + 24.255)
=32.472

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(108.216 + 0 + 1.065) - (38.7 + 0 + 64.678)
=5.903

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Qualitek Labs's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=65.911/3247.393
=2.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qualitek Labs EBIT Related Terms

Thank you for viewing the detailed overview of Qualitek Labs's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Qualitek Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qualitek Labs Ltd (BOM:544091) » Definitions » EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
C-40, near Nexa showroom, Block C, Sector 57, Noida, UP, IND, 201301
Website
https://www.qualiteklab.com
Qualitek Labs Ltd is engaged in the business of providing testing, inspection, homologation, certification, and consultancy services to various industries such as automotive, defence, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.

Qualitek Labs Headlines

No Headlines